SEI Investments’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
Other funds holding TNXP
JHC
SEI Investments's TNXP Position: Q3 2026 in Review
SEI Investments increased its Tonix Pharmaceuticals (TNXP) stake by 57% in Q3 2026, buying an estimated $247K and bringing the position to 57,360 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #2588.
SEI Investments first reported a position in TNXP in Q4 2025 and has held it in 4 quarters since. 76 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.
- SEI Investments held 57,360 shares of Tonix Pharmaceuticals worth $559K as of Q3 2026.
- SEI Investments bought 20,888 Tonix Pharmaceuticals shares in Q3 2026, an estimated $247K.
- Tonix Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2588 holding.
- SEI Investments first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- 76 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.